Correlation Between Merck and ALTICE
Specify exactly 2 symbols:
By analyzing existing cross correlation between Merck Company and ALTICE FRANCE S, you can compare the effects of market volatilities on Merck and ALTICE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of ALTICE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and ALTICE.
Diversification Opportunities for Merck and ALTICE
Very good diversification
The 3 months correlation between Merck and ALTICE is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and ALTICE FRANCE S in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALTICE FRANCE S and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with ALTICE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALTICE FRANCE S has no effect on the direction of Merck i.e., Merck and ALTICE go up and down completely randomly.
Pair Corralation between Merck and ALTICE
Considering the 90-day investment horizon Merck Company is expected to under-perform the ALTICE. In addition to that, Merck is 1.03 times more volatile than ALTICE FRANCE S. It trades about -0.07 of its total potential returns per unit of risk. ALTICE FRANCE S is currently generating about -0.01 per unit of volatility. If you would invest 7,598 in ALTICE FRANCE S on December 30, 2024 and sell it today you would lose (78.00) from holding ALTICE FRANCE S or give up 1.03% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 46.77% |
Values | Daily Returns |
Merck Company vs. ALTICE FRANCE S
Performance |
Timeline |
Merck Company |
ALTICE FRANCE S |
Merck and ALTICE Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Merck and ALTICE
The main advantage of trading using opposite Merck and ALTICE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, ALTICE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALTICE will offset losses from the drop in ALTICE's long position.The idea behind Merck Company and ALTICE FRANCE S pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.ALTICE vs. Akso Health Group | ALTICE vs. The Cheesecake Factory | ALTICE vs. HUTCHMED DRC | ALTICE vs. Viemed Healthcare |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Valuation Check real value of public entities based on technical and fundamental data |